Drugs Based on CAR T-cell Market, Global Outlook and Forecast 2022-2028

July 2022 | 68 pages | ID: D2504E07DDB9EN
Market Monitor Global

Abstracts

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer

This report contains market size and forecasts of Drugs Based on CAR T-cell in Global, including the following market information:

Global Drugs Based on CAR T-cell Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Drugs Based on CAR T-cell market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

CD19-targeted Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Drugs Based on CAR T-cell include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics and FOSUNKite, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs Based on CAR T-cell companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drugs Based on CAR T-cell Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Drugs Based on CAR T-cell Market Segment Percentages, by Type, 2021 (%)

• CD19-targeted
• BCMA-targeted

Global Drugs Based on CAR T-cell Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Drugs Based on CAR T-cell Market Segment Percentages, by Application, 2021 (%)

• Lymphoma
• Multiple Myeloma

Global Drugs Based on CAR T-cell Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Drugs Based on CAR T-cell Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drugs Based on CAR T-cell revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Drugs Based on CAR T-cell revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Gilead Sciences
• Bristol-Myers Squibb
• J & J
• JW Therapeutics
• FOSUNKite

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Drugs Based on CAR T-cell Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Drugs Based on CAR T-cell Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DRUGS BASED ON CAR T-CELL OVERALL MARKET SIZE

2.1 Global Drugs Based on CAR T-cell Market Size: 2021 VS 2028
2.2 Global Drugs Based on CAR T-cell Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Drugs Based on CAR T-cell Players in Global Market
3.2 Top Global Drugs Based on CAR T-cell Companies Ranked by Revenue
3.3 Global Drugs Based on CAR T-cell Revenue by Companies
3.4 Top 3 and Top 5 Drugs Based on CAR T-cell Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drugs Based on CAR T-cell Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs Based on CAR T-cell Players in Global Market
  3.6.1 List of Global Tier 1 Drugs Based on CAR T-cell Companies
  3.6.2 List of Global Tier 2 and Tier 3 Drugs Based on CAR T-cell Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Drugs Based on CAR T-cell Market Size Markets, 2021 & 2028
  4.1.2 CD19-targeted
  4.1.3 BCMA-targeted
4.2 By Type - Global Drugs Based on CAR T-cell Revenue & Forecasts
  4.2.1 By Type - Global Drugs Based on CAR T-cell Revenue, 2017-2022
  4.2.2 By Type - Global Drugs Based on CAR T-cell Revenue, 2023-2028
  4.2.3 By Type - Global Drugs Based on CAR T-cell Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Drugs Based on CAR T-cell Market Size, 2021 & 2028
  5.1.2 Lymphoma
  5.1.3 Multiple Myeloma
5.2 By Application - Global Drugs Based on CAR T-cell Revenue & Forecasts
  5.2.1 By Application - Global Drugs Based on CAR T-cell Revenue, 2017-2022
  5.2.2 By Application - Global Drugs Based on CAR T-cell Revenue, 2023-2028
  5.2.3 By Application - Global Drugs Based on CAR T-cell Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Drugs Based on CAR T-cell Market Size, 2021 & 2028
6.2 By Region - Global Drugs Based on CAR T-cell Revenue & Forecasts
  6.2.1 By Region - Global Drugs Based on CAR T-cell Revenue, 2017-2022
  6.2.2 By Region - Global Drugs Based on CAR T-cell Revenue, 2023-2028
  6.2.3 By Region - Global Drugs Based on CAR T-cell Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Drugs Based on CAR T-cell Revenue, 2017-2028
  6.3.2 US Drugs Based on CAR T-cell Market Size, 2017-2028
  6.3.3 Canada Drugs Based on CAR T-cell Market Size, 2017-2028
  6.3.4 Mexico Drugs Based on CAR T-cell Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Drugs Based on CAR T-cell Revenue, 2017-2028
  6.4.2 Germany Drugs Based on CAR T-cell Market Size, 2017-2028
  6.4.3 France Drugs Based on CAR T-cell Market Size, 2017-2028
  6.4.4 U.K. Drugs Based on CAR T-cell Market Size, 2017-2028
  6.4.5 Italy Drugs Based on CAR T-cell Market Size, 2017-2028
  6.4.6 Russia Drugs Based on CAR T-cell Market Size, 2017-2028
  6.4.7 Nordic Countries Drugs Based on CAR T-cell Market Size, 2017-2028
  6.4.8 Benelux Drugs Based on CAR T-cell Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Drugs Based on CAR T-cell Revenue, 2017-2028
  6.5.2 China Drugs Based on CAR T-cell Market Size, 2017-2028
  6.5.3 Japan Drugs Based on CAR T-cell Market Size, 2017-2028
  6.5.4 South Korea Drugs Based on CAR T-cell Market Size, 2017-2028
  6.5.5 Southeast Asia Drugs Based on CAR T-cell Market Size, 2017-2028
  6.5.6 India Drugs Based on CAR T-cell Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Drugs Based on CAR T-cell Revenue, 2017-2028
  6.6.2 Brazil Drugs Based on CAR T-cell Market Size, 2017-2028
  6.6.3 Argentina Drugs Based on CAR T-cell Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Drugs Based on CAR T-cell Revenue, 2017-2028
  6.7.2 Turkey Drugs Based on CAR T-cell Market Size, 2017-2028
  6.7.3 Israel Drugs Based on CAR T-cell Market Size, 2017-2028
  6.7.4 Saudi Arabia Drugs Based on CAR T-cell Market Size, 2017-2028
  6.7.5 UAE Drugs Based on CAR T-cell Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Drugs Based on CAR T-cell Major Product Offerings
  7.1.4 Novartis Drugs Based on CAR T-cell Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 Gilead Sciences
  7.2.1 Gilead Sciences Corporate Summary
  7.2.2 Gilead Sciences Business Overview
  7.2.3 Gilead Sciences Drugs Based on CAR T-cell Major Product Offerings
  7.2.4 Gilead Sciences Drugs Based on CAR T-cell Revenue in Global Market (2017-2022)
  7.2.5 Gilead Sciences Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Drugs Based on CAR T-cell Major Product Offerings
  7.3.4 Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 J & J
  7.4.1 J & J Corporate Summary
  7.4.2 J & J Business Overview
  7.4.3 J & J Drugs Based on CAR T-cell Major Product Offerings
  7.4.4 J & J Drugs Based on CAR T-cell Revenue in Global Market (2017-2022)
  7.4.5 J & J Key News
7.5 JW Therapeutics
  7.5.1 JW Therapeutics Corporate Summary
  7.5.2 JW Therapeutics Business Overview
  7.5.3 JW Therapeutics Drugs Based on CAR T-cell Major Product Offerings
  7.5.4 JW Therapeutics Drugs Based on CAR T-cell Revenue in Global Market (2017-2022)
  7.5.5 JW Therapeutics Key News
7.6 FOSUNKite
  7.6.1 FOSUNKite Corporate Summary
  7.6.2 FOSUNKite Business Overview
  7.6.3 FOSUNKite Drugs Based on CAR T-cell Major Product Offerings
  7.6.4 FOSUNKite Drugs Based on CAR T-cell Revenue in Global Market (2017-2022)
  7.6.5 FOSUNKite Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Drugs Based on CAR T-cell Market Opportunities & Trends in Global Market
Table 2. Drugs Based on CAR T-cell Market Drivers in Global Market
Table 3. Drugs Based on CAR T-cell Market Restraints in Global Market
Table 4. Key Players of Drugs Based on CAR T-cell in Global Market
Table 5. Top Drugs Based on CAR T-cell Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Drugs Based on CAR T-cell Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Drugs Based on CAR T-cell Revenue Share by Companies, 2017-2022
Table 8. Global Companies Drugs Based on CAR T-cell Product Type
Table 9. List of Global Tier 1 Drugs Based on CAR T-cell Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs Based on CAR T-cell Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Drugs Based on CAR T-cell Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Drugs Based on CAR T-cell Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Drugs Based on CAR T-cell Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Drugs Based on CAR T-cell Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Drugs Based on CAR T-cell Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Drugs Based on CAR T-cell Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Drugs Based on CAR T-cell Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Drugs Based on CAR T-cell Product Offerings
Table 32. Novartis Drugs Based on CAR T-cell Revenue (US$, Mn), (2017-2022)
Table 33. Gilead Sciences Corporate Summary
Table 34. Gilead Sciences Drugs Based on CAR T-cell Product Offerings
Table 35. Gilead Sciences Drugs Based on CAR T-cell Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Drugs Based on CAR T-cell Product Offerings
Table 38. Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue (US$, Mn), (2017-2022)
Table 39. J & J Corporate Summary
Table 40. J & J Drugs Based on CAR T-cell Product Offerings
Table 41. J & J Drugs Based on CAR T-cell Revenue (US$, Mn), (2017-2022)
Table 42. JW Therapeutics Corporate Summary
Table 43. JW Therapeutics Drugs Based on CAR T-cell Product Offerings
Table 44. JW Therapeutics Drugs Based on CAR T-cell Revenue (US$, Mn), (2017-2022)
Table 45. FOSUNKite Corporate Summary
Table 46. FOSUNKite Drugs Based on CAR T-cell Product Offerings
Table 47. FOSUNKite Drugs Based on CAR T-cell Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Drugs Based on CAR T-cell Segment by Type in 2021
Figure 2. Drugs Based on CAR T-cell Segment by Application in 2021
Figure 3. Global Drugs Based on CAR T-cell Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Drugs Based on CAR T-cell Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drugs Based on CAR T-cell Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs Based on CAR T-cell Revenue in 2021
Figure 8. By Type - Global Drugs Based on CAR T-cell Revenue Market Share, 2017-2028
Figure 9. By Application - Global Drugs Based on CAR T-cell Revenue Market Share, 2017-2028
Figure 10. By Region - Global Drugs Based on CAR T-cell Revenue Market Share, 2017-2028
Figure 11. By Country - North America Drugs Based on CAR T-cell Revenue Market Share, 2017-2028
Figure 12. US Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Drugs Based on CAR T-cell Revenue Market Share, 2017-2028
Figure 16. Germany Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 17. France Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Drugs Based on CAR T-cell Revenue Market Share, 2017-2028
Figure 24. China Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 28. India Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Drugs Based on CAR T-cell Revenue Market Share, 2017-2028
Figure 30. Brazil Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Drugs Based on CAR T-cell Revenue Market Share, 2017-2028
Figure 33. Turkey Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Drugs Based on CAR T-cell Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Gilead Sciences Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. J & J Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. JW Therapeutics Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. FOSUNKite Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2017-2022)